M. Baluom et al., Synchronized release of sulpiride and sodium decanoate from HPMC matrices:A rational approach to enhance sulpiride absorption in the rat intestine, PHARM RES, 17(9), 2000, pp. 1071-1076
Purpose. (a) To improve the absorption of sulpiride (SP) through the intest
inal wall by incorporating it together with sodium decanoate (SD) into erod
ible matrices, designed to synchronize the release of SP and SD over differ
ent periods of time; (b) to test, in vivo the hypothesis that this simultan
eous release increases SP absorption from the intestinal lumen.
Methods. Matrix tablets, possessing different erosion rates, were pre Dared
by changing the ratios between SD and hydroxypropyl methylcellulose (HPMC)
. The amounts of HPMC varied from 2.5% to 17% w/w. Double layer tablets, co
ntaining similar amounts of SP, SD, and HPMC were used as nonsynchronous co
ntrols. The erosion kinetics of the tablets was assessed gravimetrically in
vitro in USP basket dissolution apparatus and in vivo in the intestine of
the anesthetized rat after intra-intestinal administration. SP absorption w
as studied after intra-intestinal administration of the different kinds of
tablets to anesthetized rats, by monitoring SP blood levels. SP and SD leve
ls in the withdrawn samples from the dissolution systems and blood were ana
lyzed by HPLC.
Results. The controlled erosion of the tablets resulted in equal release ra
tes of SP and SD during the initial lineal phase of the process. This synch
ronized release lasted over different time periods depending on the relativ
e amount of HPMC in the formulations (from 1 hour to 4 hours for 2.5 and 17
% w/w of HPMC, respectively). The synchronous matrices increased SP bioava
ilability after intra-intestinal administration. The increase varied from 1
.4 to 2.3-fold for the slow and the fast release formulations, respectively
(compared with the nonsynchronous, SD containing control formulations), in
dicating the ability to control both erosion rate and length of intestinal
segment in which absorption is taking place.
Conclusions. SP bioavailability alter intestinal administration can be impr
oved only if SP is released together with SD along the entire intestinal ro
ute. This can he accomplished by the design of synchronous matrices capable
of concomitant release of SP and SD despite the differences in their water
solubility. The ability to manipulate and control the duration of the sync
hronous phase of the matrices makes it possible for SP to be absorbed at di
fferent parts of the intestine.